标题
Severe hypertriglyceridemia: Existing and emerging therapies
作者
关键词
-
出版物
PHARMACOLOGY & THERAPEUTICS
Volume 251, Issue -, Pages 108544
出版商
Elsevier BV
发表日期
2023-10-15
DOI
10.1016/j.pharmthera.2023.108544
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Clinical Trial Design for Triglyceride-Rich Lipoprotein-Lowering Therapies
- (2023) Waqas A. Malick et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations: a phase 2 randomized trial
- (2023) Robert S. Rosenson et al. NATURE MEDICINE
- The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial
- (2023) Deepak L. Bhatt et al. NATURE MEDICINE
- Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH
- (2023) Rohit Loomba et al. NEW ENGLAND JOURNAL OF MEDICINE
- An anti-ANGPTL3/8 antibody decreases circulating triglycerides by binding to a LPL-inhibitory leucine zipper-like motif
- (2022) Deepa Balasubramaniam et al. JOURNAL OF LIPID RESEARCH
- A Biological Rationale for the Disparate Effects of Omega-3 Fatty Acids on Cardiovascular Disease Outcomes
- (2022) Samuel C.R. Sherratt et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- ANGPTL4 silencing via antisense oligonucleotides reduces plasma triglycerides and glucose in mice without causing lymphadenopathy
- (2022) Mingjuan Deng et al. JOURNAL OF LIPID RESEARCH
- Tirzepatide Once Weekly for the Treatment of Obesity
- (2022) Ania M. Jastreboff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Guidance for the diagnosis and treatment of hypolipidemia disorders
- (2022) Cindy Bredefeld et al. Journal of Clinical Lipidology
- Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk
- (2022) Aruna Das Pradhan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetics of Triglyceride-Rich Lipoproteins Guide Identification of Pharmacotherapy for Cardiovascular Risk Reduction
- (2021) Aleesha Shaik et al. CARDIOVASCULAR DRUGS AND THERAPY
- Effects of liraglutide on the metabolism of triglyceride‐rich lipoproteins in type 2 diabetes
- (2021) Marja‐Riitta Taskinen et al. DIABETES OBESITY & METABOLISM
- Once-Weekly Semaglutide in Adults with Overweight or Obesity
- (2021) John P.H. Wilding et al. NEW ENGLAND JOURNAL OF MEDICINE
- GLP-1 (Glucagon-Like Peptide-1) Is Physiologically Relevant for Chylomicron Secretion Beyond Its Known Pharmacological Role
- (2021) Avital Nahmias et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult
- (2021) Glen J. Pearson et al. CANADIAN JOURNAL OF CARDIOLOGY
- New and Emerging Therapies for Reduction of LDL-Cholesterol and Apolipoprotein B
- (2021) Nick S. Nurmohamed et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
- (2021) Ioanna Gouni-Berthold et al. Lancet Diabetes & Endocrinology
- Niacin Increases Atherogenic Proteins in High-Density Lipoprotein of Statin-Treated Subjects
- (2021) Graziella E. Ronsein et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society
- (2021) Henry N Ginsberg et al. EUROPEAN HEART JOURNAL
- Directly measured vs. calculated remnant cholesterol identifies additional overlooked individuals in the general population at higher risk of myocardial infarction
- (2021) Anette Varbo et al. EUROPEAN HEART JOURNAL
- Inhibition of Angiopoietin-Like Protein 3 With Evinacumab in Subjects With High and Severe Hypertriglyceridemia
- (2021) Zahid Ahmad et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia
- (2021) Salim S. Virani et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The association of triglyceride levels with the incidence of initial and recurrent acute pancreatitis
- (2021) Robert J. Sanchez et al. Lipids in Health and Disease
- New Therapies for Lowering Triglyceride-Rich Lipoproteins
- (2021) Robert S. Rosenson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Alcohol effects on hepatic lipid metabolism
- (2020) Sookyoung Jeon et al. JOURNAL OF LIPID RESEARCH
- Angiopoietin-like protein 3 (ANGPTL3) governs LDL-cholesterol levels through endothelial lipase-dependent VLDL clearance
- (2020) Rene C. Adam et al. JOURNAL OF LIPID RESEARCH
- Angiopoietin-like protein 8 differentially regulates ANGPTL3 and ANGPTL4 during postprandial partitioning of fatty acids
- (2020) Yan Q. Chen et al. JOURNAL OF LIPID RESEARCH
- Genetics of Hypertriglyceridemia
- (2020) Jacqueline S. Dron et al. Frontiers in Endocrinology
- The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans
- (2020) Jan Borén et al. Frontiers in Endocrinology
- LDL-Cholesterol Reduction by ANGPTL3 Inhibition in Mice Is Dependent on Endothelial Lipase
- (2020) Liya Wu et al. CIRCULATION RESEARCH
- A Comprehensive Update on the Chylomicronemia Syndrome
- (2020) Ronald B. Goldberg et al. Frontiers in Endocrinology
- Triglyceride-Rich Lipoprotein Remnants and Cardiovascular Disease
- (2020) Edward K Duran et al. CLINICAL CHEMISTRY
- Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk
- (2020) Stephen J. Nicholls et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- N-acetyl galactosamine-conjugated antisense drug to APOC3 mRNA, triglycerides and atherogenic lipoprotein levels
- (2019) Veronica J Alexander et al. EUROPEAN HEART JOURNAL
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia
- (2019) Zahid Ahmad et al. CIRCULATION
- Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association
- (2019) Ann C. Skulas-Ray et al. CIRCULATION
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- Characterization of ANGPTL4 function in macrophages and adipocytes using Angptl4-knockout and Angptl4-hypomorphic mice
- (2019) Antwi-Boasiako Oteng et al. JOURNAL OF LIPID RESEARCH
- Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome
- (2019) Joseph L. Witztum et al. NEW ENGLAND JOURNAL OF MEDICINE
- APOC3Loss-of-Function Mutations, Remnant Cholesterol, Low-Density Lipoprotein Cholesterol, and Cardiovascular RiskHighlights
- (2018) Anders B. Wulff et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Effects of n−3 Fatty Acid Supplements in Diabetes Mellitus
- (2018) NEW ENGLAND JOURNAL OF MEDICINE
- Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
- (2018) JoAnn E. Manson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
- (2018) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- ANGPTL8 requires ANGPTL3 to inhibit lipoprotein lipase and plasma triglyceride clearance
- (2017) Jorge F. Haller et al. JOURNAL OF LIPID RESEARCH
- Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease
- (2017) Frederick E. Dewey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
- (2017) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- FGF21 Lowers Plasma Triglycerides by Accelerating Lipoprotein Catabolism in White and Brown Adipose Tissues
- (2016) Christian Schlein et al. Cell Metabolism
- Effects of bariatric surgery on hepatic and intestinal lipoprotein particle metabolism
- (2016) Satya Dash et al. CURRENT OPINION IN LIPIDOLOGY
- Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease
- (2016) NEW ENGLAND JOURNAL OF MEDICINE
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease
- (2016) Frederick E. Dewey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nonfasting Mild-to-Moderate Hypertriglyceridemia and Risk of Acute Pancreatitis
- (2016) Simon B. Pedersen et al. JAMA Internal Medicine
- Hypertriglyceridemia in the Genomic Era: A New Paradigm
- (2015) Gary F. Lewis et al. ENDOCRINE REVIEWS
- Minireview: Roles of Fibroblast Growth Factors 19 and 21 in Metabolic Regulation and Chronic Diseases
- (2015) Fangfang Zhang et al. MOLECULAR ENDOCRINOLOGY
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
- (2014) Anders Berg Jørgensen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting APOC3 in the Familial Chylomicronemia Syndrome
- (2014) Daniel Gaudet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: The EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial
- (2013) John J.P. Kastelein et al. Journal of Clinical Lipidology
- Abetalipoproteinemia and homozygous hypobetalipoproteinemia: a framework for diagnosis and management
- (2013) Jooho Lee et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Severe Hypertriglyceridemia With Pancreatitis
- (2013) Frank M. Sacks et al. JAMA Internal Medicine
- The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
- (2013) Robert A Hegele et al. Lancet Diabetes & Endocrinology
- Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity
- (2012) Martin Adiels et al. ATHEROSCLEROSIS
- Postprandial metabolism of meal triglyceride in humans
- (2012) Jennifer E. Lambert et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Role of the Gut in Lipid Homeostasis
- (2012) Nada A. Abumrad et al. PHYSIOLOGICAL REVIEWS
- Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Patients With Very High Triglyceride Levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] Trial)
- (2011) Harold E. Bays et al. AMERICAN JOURNAL OF CARDIOLOGY
- An Increased Burden of Common and Rare Lipid-Associated Risk Alleles Contributes to the Phenotypic Spectrum of Hypertriglyceridemia
- (2011) Christopher T. Johansen et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Allelic and phenotypic spectrum of plasma triglycerides
- (2011) Christopher T. Johansen et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- The mechanism of the formation and secretion of chylomicrons
- (2010) Tammy Kindel et al. ATHEROSCLEROSIS SUPPLEMENTS
- Genetic determinants of plasma triglycerides
- (2010) Christopher T. Johansen et al. JOURNAL OF LIPID RESEARCH
- Exome Sequencing,ANGPTL3Mutations, and Familial Combined Hypolipidemia
- (2010) Kiran Musunuru et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prescription Omega-3 Fatty Acid as an Adjunct to Fenofibrate Therapy in Hypertriglyceridemic Subjects
- (2009) Eli M Roth et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection
- (2008) T. I. Pollin et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search